Survey to Assess Potential Acceptance of COVID 19 Vaccine in Pregnant and Lactating Women
- Conditions
- Pregnant and Lactating Women
- Registration Number
- CTRI/2021/04/032615
- Lead Sponsor
- NA
- Brief Summary
survey will be conducted using physical form as well as electronic form which will be filled by representee in the presence of individuals after full filling the inclusion and exclusion criteria. the survey includes demographic question as well as self prepared questionnaire. the survey is specific to individuals visiting OB-GYN and is limited to those individuals who are pregnant and lactating women. the survey may focus on different types of topics such as demographic information, risk assessment, current status of the patient, potential acceptance toward vaccine during pregnancy and lactation. Consent form will be available in English and Kannada language. Upon the subject agreement to participate in the given consent form they will be able to respond through questionnaire.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Female
- Target Recruitment
- 300
Pregnant and Lactating Women.
Women who are surrogates are not eligible for the study Women who are not willing to participate due to any reason.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method at the end of the survey we will be able to determine prevalence and acceptance of COVID 19 vaccine in pregnant and lactating population 24 weeks
- Secondary Outcome Measures
Name Time Method Barriers faced by pregnant and lactating women to get vaccinated 24 weeks
Trial Locations
- Locations (1)
Kasturba Medical College and Hospital, MAHE
🇮🇳Udupi, KARNATAKA, India
Kasturba Medical College and Hospital, MAHE🇮🇳Udupi, KARNATAKA, IndiaDr Kanav KheraPrincipal investigator7889271828kanavworld@gmail.com